Physician

Adam Joseph Palo, O.D.

According to 2025 Medicare claims, Adam Palo, O.D. (NPI: 1396014486) practices optometrist in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is EYE INSTITUTE OD (NPI: 1093226383; TIN: 82-2261271) and primary practice location at 27604-1152.

Palo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 138 traditional Medicare patients, billed 501 HCPCS/CPT codes, and received $16,341 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 74 prescription claims across 32 beneficiaries totaling $21,311 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 21 records totaling $847. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $65,722 to $16,341. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $50,786 to $21,311. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$33K$66K2015 Medicare payment: $65,722 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $45,215 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $6,892 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,885 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,870 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,490 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,710 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $9,205 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $14,475 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $16,341 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152791,052$65,722
2016311816$45,215
201760333$6,892
201854369$5,885
201937337$4,870
20205686$5,490
20214378$4,710
202296418$9,205
2023155534$14,475
2024138501$16,341

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$25K$51K2015 Drug cost: $50,786 (USD; Tot_Drug_Cst)2016 Drug cost: $50,089 (USD; Tot_Drug_Cst)2017 Drug cost: $23,663 (USD; Tot_Drug_Cst)2018 Drug cost: $11,524 (USD; Tot_Drug_Cst)2019 Drug cost: $1,793 (USD; Tot_Drug_Cst)2020 Drug cost: $3,571 (USD; Tot_Drug_Cst)2021 Drug cost: $7,275 (USD; Tot_Drug_Cst)2022 Drug cost: $6,557 (USD; Tot_Drug_Cst)2023 Drug cost: $7,746 (USD; Tot_Drug_Cst)2024 Drug cost: $21,311 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201591370$50,786
201674383$50,089
201749102$23,663
20181633$11,524
2019N/R17$1,793
20201635$3,571
2021N/R53$7,275
20222471$6,557
20233273$7,746
20243274$21,311

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system2525$89
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1921$68
92014Established patient complete exam of visual system4343$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3953$58
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more2130$36

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine14480$9,905
Prednisolone AcetatePrednisolone Acetate13737$828

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$847Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Joseph Palo, O.D.?

Tedicare shows public-source Medicare data for Adam Joseph Palo, O.D. (NPI 1396014486), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Joseph Palo, O.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Joseph Palo, O.D.?

Adam Joseph Palo, O.D. is linked to EYE INSTITUTE OD (billing NPI 1093226383) in the available physician profile data.

Does Adam Joseph Palo, O.D. have Open Payments data?

Adam Joseph Palo, O.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.